United Therapeutics Corporation
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $1.08B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $230.4M | 21.4% |
| Business Acquisitions | $89.2M | 8.3% |
| Other Investing | $400.0M | 37.1% |
| Other Financing | $11.9M | 1.1% |
| Working Capital | $99.1M | 9.2% |
| Net Cash Flow | $246.5M | 22.9% |